These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24550344)

  • 1. Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.
    Yu M; Peng B; Chan K; Gong R; Yang H; Delaney W; Cheng G
    Antimicrob Agents Chemother; 2014 May; 58(5):2638-46. PubMed ID: 24550344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations.
    Aloia AL; Eyre NS; Black S; Bent SJ; Gaeguta A; Guo Z; Narayana SK; Chase R; Locarnini S; Carr JM; Howe JA; Beard MR
    Antivir Ther; 2015; 20(3):271-80. PubMed ID: 25222708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems.
    Camus G; Xu S; Han B; Lu J; Dvory-Sobol H; Yu M; Cheng G; Miller MD; Doehle BP; Mo H
    Virology; 2018 Jan; 514():134-141. PubMed ID: 29175627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.
    Wose Kinge CN; Espiritu C; Prabdial-Sing N; Sithebe NP; Saeed M; Rice CM
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5386-94. PubMed ID: 24982066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.
    Saeed M; Scheel TK; Gottwein JM; Marukian S; Dustin LB; Bukh J; Rice CM
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5365-73. PubMed ID: 22869572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon.
    Graziani R; Paonessa G
    J Gen Virol; 2004 Jul; 85(Pt 7):1867-1875. PubMed ID: 15218171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient replication of a hepatitis C virus genotype 1b replicon chimera encoding NS5A-5B from genotype 3a.
    Kylefjord H; Danielsson A; Sedig S; Belda O; Wiktelius D; Vrang L; Targett-Adams P
    J Virol Methods; 2014 Jan; 195():156-63. PubMed ID: 24120570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.
    Herlihy KJ; Graham JP; Kumpf R; Patick AK; Duggal R; Shi ST
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3523-31. PubMed ID: 18694956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon.
    Shimakami T; Hijikata M; Luo H; Ma YY; Kaneko S; Shimotohno K; Murakami S
    J Virol; 2004 Mar; 78(6):2738-48. PubMed ID: 14990694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
    Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a.
    Robinson M; Yang H; Sun SC; Peng B; Tian Y; Pagratis N; Greenstein AE; Delaney WE
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3099-106. PubMed ID: 20516274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
    Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
    J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the unique characteristics of hepatitis C virus genotype 3 revealed by development of a robust sub-genomic DBN3a replicon.
    Ward JC; Bowyer S; Chen S; Fernandes Campos GR; Ramirez S; Bukh J; Harris M
    J Gen Virol; 2020 Nov; 101(11):1182-1190. PubMed ID: 32897181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
    Chen M; Xu Y; Li N; Yin P; Zhou Q; Feng S; Wu T; Wei L; Wang H; Fu Y; Li YP
    J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34949310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-complementation of HCV replication by non-structural protein 5A.
    Tong X; Malcolm BA
    Virus Res; 2006 Feb; 115(2):122-30. PubMed ID: 16146661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of robust hepatitis C virus genotype 4 subgenomic replicons.
    Peng B; Yu M; Xu S; Lee YJ; Tian Y; Yang H; Chan K; Mo H; McHutchison J; Delaney W; Cheng G
    Gastroenterology; 2013 Jan; 144(1):59-61.e6. PubMed ID: 23000598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-competent chimeric hepatitis C virus subgenomic replicons.
    Lemm JA; Liu M; Rose RE; Fridell R; O'Boyle Ii DR; Colonno R; Gao M
    Intervirology; 2005; 48(2-3):183-91. PubMed ID: 15812193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
    Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
    J Virol; 2019 May; 93(10):. PubMed ID: 30842319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.